MedTrace Logo

Single Cell Sequencing Analysis of Thymoma

NCT04162691 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2023-01-13

No results posted yet for this study

Summary

The purpose of this study is to understand how genetics play a role in thymoma. Intratumoral heterogeneity is among the greatest challenges in precision cancer therapy. However, developments in high-throughput single-cell RNA sequencing (scRNA-seq) may now provide the statistical power to dissect the diverse cellular populations of tumors. This study aims to find out how it affects genetic and protein expression in patients with malignant thymoma, compared to Benign thymoma, at a single-cell level using a flow cytometry and RNA-sequencing protocol.

Conditions

  • Thymoma

Interventions

DIAGNOSTIC_TEST

Tissue

Four 4-5 mm tissues of the thymoma

Sponsors & Collaborators

  • Zhejiang Cancer Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-06
Primary Completion
2021-06-01
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04162691 on ClinicalTrials.gov